For the quarter ended December 2025, Lemonade (LMND) reported revenue of $228.1 million, up 53.3% over the same period last year. EPS came in at -$0.29, compared to -$0.42 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $216.67 million, representing a surprise of +5.28%. The company delivered an EPS surprise of +28.97%, with the consensus EPS estimate being -$0.41.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...

Key Takeaways CVNA reported Q4 EPS of $4.22, topping estimates as revenues climbed 58% year over year.Retail unit sales jumped 43% to 163,522, driving a 62.9% surge in retail vehicle revenues.Carvana expects strong 2026 growth in retail units and adjusted EBITDA, with Q1 gains ahead.Used car e-retailer Carvana (CVNA) reported fourth-quarter 2025 earnings of $4.22 per share, which surpassed the Zacks Consensus Estimate of $1.13 and rose from the year-ago quarter’s earnings of 56 cents. Better-than-expected r ...

Core Insights - The S&P 500 index experienced a rise as investors reacted to mixed signals from the Federal Reserve regarding interest rates and inflation [1] - The Federal Reserve maintained interest rates but showed divided opinions on future actions, with some officials open to rate hikes if inflation persists, while others may consider cuts if inflation eases [1] - Recent economic data showed unexpected cooling in inflation, strong job growth, and a decrease in unemployment, contributing to ongoing market volatility [2] Value Investing - Value investing focuses on acquiring stocks priced below their intrinsic value, allowing investors to buy low and potentially profit later [3] - A key metric for value investors is earnings yield, which indicates the profit a company generates per dollar of its stock price, calculated as (Annual Earnings per Share/Market Price) x 100 [4] - Earnings yield can be compared to bond returns, such as the 10-year Treasury yield, to assess the attractiveness of stocks relative to fixed-income securities [5] Screening Criteria - A primary screening criterion for stock selection is an earnings yield greater than 10%, supplemented by estimated EPS growth for the next 12 months that meets or exceeds the S&P 500 average [6] - Additional criteria include an average daily trading volume of at least 100,000 shares and a current stock price of $5 or higher [7][8] Selected Stocks - Five stocks that meet the screening criteria include DaVita (DVA), Ford (F), Centerra Gold (CGAU), Southwest Airlines (LUV), and Patria Investments Limited (PAX), all showing strong earnings growth estimates [9] - DaVita is projected to have earnings growth of 31% and 19% for 2026 and 2027, respectively, with recent EPS estimates increasing by $1.59 and $2.38 [10] - Ford's earnings are expected to grow by 40% and 19% in 2026 and 2027, with EPS estimates rising by $0.05 each over the past month [11] - Centerra Gold anticipates earnings growth of 45% and 57% for 2026 and 2027, with EPS estimates increasing by $0.05 and $0.17 [12] - Southwest Airlines forecasts significant earnings growth of 362% and 17% for 2026 and 2027, with recent EPS estimates up by $0.17 and $0.08 [13] - Patria Investments expects earnings growth of 25% and 17% for 2026 and 2027, with EPS estimates rising by $0.04 and $0.07 [14]

Key Takeaways Figma beat Q4 estimates with 8-cent EPS and 40% revenue growth to $303.7M.Figma expanded its base, with 13,861 customers above $10K ARR and 1,405 above $100K ARR.Figma sees 2026 revenues of $1.366B-$1.374B and operating income of $100M-$110M.Figma (FIG) came out with fourth-quarter 2025 earnings of 8 cents per share, beating the Zacks Consensus Estimate by 14.3%. The company reported earnings of 6 cents per share in the year-ago quarter.Figma posted revenues of $303.7 million in the fourth qua ...

Integer (ITGR) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.7 per share. This compares to earnings of $1.43 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.62%. A quarter ago, it was expected that this medical device outsource manufacturer would post earnings of $1.68 per share when it actually produced earnings of $1.79, delivering a surprise of +6.55%.Over the last four q ...

Wall Street analysts forecast that Jazz Pharmaceuticals (JAZZ) will report quarterly earnings of $6.62 per share in its upcoming release, pointing to a year-over-year increase of 0.3%. It is anticipated that revenues will amount to $1.18 billion, exhibiting an increase of 8.4% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 13% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have re ...

In its upcoming report, HP (HPQ) is predicted by Wall Street analysts to post quarterly earnings of $0.77 per share, reflecting an increase of 4.1% compared to the same period last year. Revenues are forecasted to be $14.06 billion, representing a year-over-year increase of 4.1%.Over the last 30 days, there has been a downward revision of 1.8% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecas ...

In its upcoming report, Expeditors International (EXPD) is predicted by Wall Street analysts to post quarterly earnings of $1.46 per share, reflecting a decline of 13.1% compared to the same period last year. Revenues are forecasted to be $2.8 billion, representing a year-over-year decrease of 5.3%.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this ...

Wall Street analysts forecast that Cava Group (CAVA) will report quarterly earnings of $0.03 per share in its upcoming release, pointing to a year-over-year decline of 40%. It is anticipated that revenues will amount to $268.17 million, exhibiting an increase of 17.9% compared to the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prio ...

Wall Street analysts forecast that Globus Medical (GMED) will report quarterly earnings of $1.06 per share in its upcoming release, pointing to a year-over-year increase of 26.2%. It is anticipated that revenues will amount to $787.85 million, exhibiting an increase of 19.9% compared to the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during thi ...